Status: current, Defined. Date: 30-Nov 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4485821000168116 | Libtayo (cemiplimab 350 mg / 7 mL) injection, 7 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4485831000168118 | Libtayo 350 mg/7 mL injection, 7 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Libtayo 350 mg/7 mL injection, 7 mL vial | Is a | Libtayo | true | Inferred relationship | Some | ||
| Libtayo 350 mg/7 mL injection, 7 mL vial | Is a | cemiplimab 350 mg/7 mL injection, vial | true | Inferred relationship | Some | ||
| Libtayo 350 mg/7 mL injection, 7 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Libtayo 350 mg/7 mL injection, 7 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Libtayo 350 mg/7 mL injection, 7 mL vial | has Australian BoSS | cemiplimab | true | Inferred relationship | Some | 1657478590 | |
| Libtayo 350 mg/7 mL injection, 7 mL vial | has intended active ingredient | cemiplimab | true | Inferred relationship | Some | 1657478590 | |
| Libtayo 350 mg/7 mL injection, 7 mL vial | has unit of use | vial | true | Inferred relationship | Some | 900071113 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Libtayo 350 mg/7 mL injection, 7 mL vial | has TPUU | True | Libtayo 350 mg/7 mL injection, 7 mL vial | Inferred relationship | Some | 1272344354 |
| Libtayo 350 mg/7 mL injection, 7 mL vial | has TPUU | True | Libtayo 350 mg/7 mL injection, 7 mL vial | Inferred relationship | Some | 953440329 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR